Episodic Future Thinking for Type 2 Diabetes

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Type 2 Diabetes+1 MoreEpisodic Future Thinking - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare the effects of episodic future thinking (EFT) on delaying discounting in adults with type 2 diabetes.

Eligible Conditions
  • Type 2 Diabetes
  • Overweight and Obesity

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 7 Secondary · Reporting Duration: Week 24

Baseline, Week 24
Change in body mass index from baseline (Week 0) to Week 24
Change in delay discounting from baseline (Week 0) to Week 24
Change in dietary intake from baseline (Week 0) to Week 24
Change in glycemic control from baseline (Week 0) to Week 24
Change in physical activity from baseline (Week 0) to Week 24
Change in self-reported adherence to glucose-lowering medication from baseline (Week 0) to Week 24
Baseline, Week 8
Change in body mass index from baseline (Week 0) to Week 8
Change in delay discounting from baseline (Week 0) to Week 8
Change in dietary intake from baseline (Week 0) to Week 8
Change in glycemic control from baseline (Week 0) to Week 8
Change in physical activity from baseline (Week 0) to Week 8
Change in self-reported adherence to glucose-lowering medication from baseline (Week 0) to Week 8
Week 24
Ease of Use and Treatment Effectiveness Questionnaire, Likert scale

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Healthy Information Thinking
1 of 2
Episodic Future Thinking
1 of 2

Active Control

Experimental Treatment

120 Total Participants · 2 Treatment Groups

Primary Treatment: Episodic Future Thinking · No Placebo Group · N/A

Episodic Future Thinking
Behavioral
Experimental Group · 1 Intervention: Episodic Future Thinking · Intervention Types: Behavioral
Healthy Information Thinking
Behavioral
ActiveComparator Group · 1 Intervention: Healthy Information Thinking · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Episodic Future Thinking
2018
N/A
~240

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: week 24

Who is running the clinical trial?

Virginia Polytechnic Institute and State UniversityLead Sponsor
111 Previous Clinical Trials
25,693 Total Patients Enrolled
University at BuffaloOTHER
123 Previous Clinical Trials
93,494 Total Patients Enrolled
Carilion ClinicOTHER
64 Previous Clinical Trials
12,248 Total Patients Enrolled
Jeffrey Stein, PhDPrincipal InvestigatorFralin Biomedical Research Institute at Virginia Tech Carilion

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a HbA1c greater than or equal to 7.
You have a body mass index greater than or equal to 30.